西替利嗪联合卡介菌多糖核酸治疗儿童过敏性紫癜的疗效分析.docVIP

關嵋关菌多縮丿 轴析 2018-03-29 10:29:58中国现代医生2018年6期 林志波黄海忠任燕妮 ［摘要］戸的探討儿童过敏性紫瘢行西替利嗪联合卡介菌多糖核酸治疗的疗效。方法回顾性分 析2016年1月?2017年“月84例儿童过敏性紫瘢患儿并分组。对照组用西替利嗪行常规治疗， 联合用药组行西替利嗪联合卡介菌多糖核酸治疗。比较两组儿童过敏性紫瘢转归率；皮肤紫瘢、腹部 症状、下肢症状消失时间、尿检恢复正常时间；干预前后患儿血浆免疫球蛋白水平、血浆组胺水平、 炎症水平；药物不良反应出现率。结果联合用药组儿童过敏性紫瘢转归率高于对照组(PvO.05)； 联合用药组皮朕紫瘢、腹部症状、下肢症状消失时间、尿检恢复正常时间短于对照组(P0.05)；干 预前两组血浆免疫球蛋白水平、血浆组胺水平、炎症水平相近(P0.05)；干预后联合用药组血浆免 疫球蛋白水平、血浆组胺水平、炎症水平优于对照组(P0.05)o两组均未出现严重不良反应(P0.05)o 结论儿童过敏性紫瘢行西替利嗪联合卡介菌多糖核酸治疗的疗效确切，优于单一用药，可更好降低 血浆免疫球蛋白水平、血浆组胺水平、炎症水平，加速症状和检查结果复常，缩短疗程，无明显副作 用，安全有效。 ［关键词］儿童过敏性紫瘢；西替利嗪；卡介菌多糖核酸 ［中图分类号］R683.4 ［文献标识码］B ［文章编1673-9701 (2018) 06-0053-03 ［Abstract］ Objective To investigate the clinical effectiveness of treatment combining cetirizine and BCG PSN in children with henoch-schonlein purpura (HSP)? Methods 84 children in our hospital from January 2016 to November 2017 were reviewed and divided into two groups? Children in control group were treated with cetirizi ne as the conventional treatment. Childre n in combi nation treatme nt group were treated with cetirizine and BCG PSN. The rate of prog no sis, time of the disappearance of skin purpura, abdominal symptoms and lower extremity symptoms as well as the time of urine test back to normal level were compared in children of two groups? The levels of immuno globulin in plasma, histamine in plasma, in flammati on and the in cident of adverse effects before and after intervention were compared? Results The rate of prognosis of children in combi nation treatment group was higher than that in control group (P0.05) . The time of the disappearance of skin purpura, abdominal symptoms and lower extremity symptoms as well as the time of urine test back to normal level in combination treatment group were shorter than those in the control group (P0.05)? The levels of immunoglobulin in plasma, histamine in plasma and inflammation in two groups before intervention were not significantly different (P0.05) . The levels of these indicators in combination treatment group after in